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Abstract Obesity is a multifactorial disease linked to
metabolic chronic disorders such as diabetes, and hyper-
tension. Also, it has recently been associated with skeletal
alterations and low bone mineral density. We previously
demonstrated that exposure of osteoblasts to sera of
sedentary subjects affected by obesity alters cell home-
ostasis in vitro, leading to disruption of intracellular dif-
ferentiation pathways and cellular activity. Thus, the
purpose of the present study has been to evaluate whether
sera of sedentary obese women, subjected to physical
activity and hypocaloric diet, could recover osteoblast
homeostasis in vitro as compared to the sera of same
patients before intervention protocol. To this aim, obese
women were evaluated at time 0 and after 4, 6, and
12 months of individualized prescribed physical activity
and hypocaloric diet. Dual-energy-X-ray absorptiometry
measurements were performed at each time point, as well as
blood was collected at the same points. Cells were incu-
bated with sera of subjects before and after physical activity
as described: obese at baseline and after for 4, 6, and
12 months of physical activity and nutritional protocol
intervention. Osteoblasts exposed to sera of patients, who
displayed increased lean and decreased fat mass (from
55.5± 6.5 to 57.1± 5.6% p ≤ 0.05; from 44.5± 1.1 to
40.9± 2.6% p ≤ 0.01 respectively), showed a time-
dependent increase of Wnt/β-catenin signaling, versus
cells exposed to sera of obese patients before intervention
protocol, suggesting recovery of osteoblast homeostasis
upon improvement of body composition. An increase in
β-catenin nuclear accumulation and nuclear translocation
was also observed, accompanied by an increase in Adipo-
nectin receptor 1 protein expression, suggesting positive
effect on cell differentiation program. Furthermore, a
decrease in sclerostin amount and an increase of type
1 procollagen amino-terminal-propeptide were depicted as
compared to baseline, proportionally to the time of physical
activity, suggesting a recovery of bone remodeling mod-
ulation and an increase of osteoblast activity induced by
improvement of body composition. In conclusion, our
results show for the first time that sera of obese sedentary
women who increased lean mass and decreased fat mass, by
physical activity and hypocaloric diet, rescue osteoblasts
differentiation and activity likely due to a reactivation of
Wnt/β-catenin-pathway, suggesting that a correct life style
can improve skeletal metabolic alteration induced by
obesity.
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Introduction
Obesity and osteoporosis are pandemic health problems
with high prevalence and impact on mortality, morbidity,
disability, and quality of life in affected individuals [1, 2].
During the last decades, both diseases have become a major
health threat around the world, with age and female status
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increasing the risk of developing both obesity and osteo-
porosis [1, 2].
Interestingly, obesity has been considered a risk factor for
several metabolic chronic diseases (i.e. cardiovascular dis-
ease, diabetes mellitus) but a protection factor against the
development of bone loss and osteoporosis, likely for both
an increased androgen aromatization to estrogens in post-
menopausal obese women [3, 4] and a potential role of
mechanical loading in regulating bone remodeling [5].
Recently, however, the belief that obesity is protective
against osteoporosis has been questioned. In fact, epide-
miologic and clinical studies suggest that high level of
abdominal fat mass might be a risk factor for a loss of bone
density and/or quality leading to osteoporosis and fragility
fractures [6–8]. Adipose tissue functions as an endocrine
organ by releasing several adipokines, which seem to
modulate glucose and lipid metabolism, inflammation and
insulin resistance [9–11]. A pathological implication of
adipose tissue for skeletal health could possible resides in
the role that pro-inflammatory cytokines might play by
interfering with bone remodeling [12–15]. More recently,
obesity has also been associated to sarcopenia, a condition
characterized by progressive decline of muscle mass, qual-
ity, and strength [16, 17]. Further, as above mentioned,
obesity is associated with a chronic low-grade inflammation
as depicted by increased plasma levels of C-reactive protein,
pro-inflammatory cytokines, and osteopontin [18, 19] as
well as lower circulating levels of Vitamin D (Vit D) [20].
Thus, the interplay between fat and bone might play an
important role as homeostatic feedback system in which
adipokines and molecules secreted by bone or adipose cells
represent the link of an active and functional bone-adipose-
muscle axis [21–24], by mechanism(s) not fully clarified yet.
Remarkably, our group recently demonstrated that
exposure of osteoblasts in vitro to the sera of sedentary
obese women, affected by abdominal fat tissue accumula-
tion, significantly disrupted osteoblast homeostasis by a
Wnt/β-catenin-dependent mechanism [25].
Thus, aim of the present study was to investigate whether
serum factors in sedentary obese women who underwent an
improvement of body composition, due to physical activity
protocol and hypocaloric diet, could positively influence
osteoblastic cells activity and differentiation recovering
bone cells homeostasis in vitro as compared to the serum of
the same subjects before intervention protocol.
Materials and methods
Subjects
Twenty-eight adult female (mean age 53 ± 8.2 years)
affected by obesity (BMI ≥ 30 kg/m2) were selected in the
Department of Experimental Medicine, Section of Medi-
cal Pathophysiology, Endocrinology, and Nutrition, of
Policlinico Umberto I, Sapienza University of Rome.
Twenty women were in menopause and eight women
were in climacteric period, diagnosed by low estrogen
levels and alterations of menstrual cycle. Chronic medical
conditions (i.e. reumatological, gastroenterological
pathologies, etc), use of medications affecting bone
metabolism, hormonal and nutritional status, Vitamin D
supplementation, recent weight loss, and prior bariatric
surgery interventions were considered as exclusion cri-
teria. Four subjects were diabetic, but they took anti-
diabetic oral medication, which did not affect mineral or
inflammatory status. All subjects provided a written
informed consent and the study was approved by the
Local Ethical Committee. All subjects were sedentary and
they had not been previously engaged in regular physical
exercise. Subsequently, patients underwent an adequate
physical activity program in combination with a hypoca-
loric equilibrate diet. After 4, 6, and 12 months patients
were characterized for their body composition. The sera of
obese women that showed, after physical activity and diet,
an increased muscle mass and decrease abdominal fat
tissue were used to culture osteoblasts and perform
in vitro experiments.
Nutritional evaluation
Dietary counseling was performed by a nutritionist and a
hypocaloric diet was set at approximately 400 Kcal less than
total daily energy expenditure. Total daily energy expen-
diture was determined by considering the resting metabolic
rate and the physical activity level [26]. Physical activity
level was estimated by the international physical activity
questionnaire [27].
Physical activity program
The obese women enrolled in the study performed an
unsupervised 12-months daily aerobic training based on a
walking speed and on the value of RPE-OMNI-Walk/Run
scale corresponding to their individual ventilatory threshold
[28, 29]. The training session duration varied lasting 30 min
the first 2 months and 60 min the following 10 months. Each
subject filled a physical activity diary day-by-day over the
period of training. Every 2 months, subject’s gait speed and
RPE-OMNI-Walk/Run scale value, corresponding to indi-
vidual ventilator threshold, were revaluated in order to
prescribe a new work load for the following training period
in order to maintain the individual aerobic exercise intensity
constant during the 12 months.
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Body composition
Each subject’s height was measured using a stadiometer to
the nearest 0.1 cm. Percentage of fat mass (%FM), muscle
mass in kilograms (FFM), bone density and body mass
index (BMI) were assessed by dual-energy-X-ray absorp-
tiometry (DXA, Hologic 4500 RDR). Amount of trunk fat
mass was distinguished from peripheral and appendicular
fat mass as a measure of abdominal adiposity by DXA with
coefficient of variation of <1% for bone density and <1.5%
for fat mass [7]. In particular, trunk fat was defined as the
adipose tissue localized within the region below the chin,
delineated by vertical lines within the left and right glenoid
fossae bordering laterally to the ribs, and by the oblique
lines that cross the femoral necks and converge below the
pubic symphysis.
Cell culture
Human SAOS-2 osteoblastic cells were cultured in Dul-
becco’s modified Eagle’s medium without Phenol Red,
supplemented with 2 mM L-glutamine, 100 U/mL penicillin/
streptomycin, 10% fetal bovine serum, at 37 °C and 5%
CO2 in a humidified incubator. Before starting each
experiment, a pool from five different patients sera from the
same time group was prepared and used for cellular treat-
ments. Cells were grown up to 70% confluence, starved
overnight in a medium serum-free, and then incubated 48 h
with medium supplemented with 20% patients sera pools
[25]. All buffers, media, and reagents were purchased from
Euroclone (Milan, Italy). Cells were incubated with sera of
subjects before and after physical activity as described: (1)
obese (T0), (2) obese after for 4 months (T4), (3) obese after
6 months (T6), (4) obese after for 12 months of physical
activity and nutritional protocol intervention (T12).
Protein extraction and western blot analysis
Following experimental treatments, cells were washed twice
with 1× PBS, collected with scraper, and to extract total
proteins, lysed in ice-cold RIPA buffer supplemented with
protease and phosphatase inhibitor cocktails (Sigma-
Aldrich, St. Louis, MO, USA).
For protein fraction analysis, lysates were precleared by
centrifugation and supernatant (total proteins) was collected
and stored at −80 °C until use. NE-PER nuclear and cyto-
plasmic extraction Reagents (Thermo Fisher Scientific,
Waltham, MA, USA) were used to extract nuclear and
cytosolic fraction of cell proteins, following manufacturer’s
protocol. Protein amount was measured by using the
Pierce® BCA protein assay kit (Thermo Fisher Scientific).
An equal amount of protein extracts (20 μg) were resolved
in SDS-polyacrylamide gels (10–14%) and transferred to
nitrocellulose membranes (Amersham Biosciences, Pitts-
burgh, PA, USA). Membranes were saturated by incubation
at RT for 1 h with 5% (w/v) non-fat dry milk in 20 mM
Tris–HCl, 150 mM NaCl, 0.05% Tween 20 and incubated
with specific antibodies overnight at 4 °C.
Antibodies against β-catenin, tubulin and histone H3 were
purchased from Abcam (Cambridge, UK), anti-TCF1, anti c-
Myc, anti c-Jun, and anti-CD44 antibody were purchased
from Cell Signaling (Danvers, MA, USA). Cyclin D1 and
adiponectin receptor-1 (AdipoR1) were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA, USA). All primary
antibodies were diluted 1:1000 in 1× TBST with 5% BSA or
5% non fat dry milk and incubated over night at +4 °C.
The immunoreactive protein bands were detected by
incubation for 1 h with horseradish peroxidase-conjugated
secondary goat anti-rabbit or goat anti-mouse (Jackson
Laboratories, Bar Harbor, ME, USA, 1:10000) in blocking
solution at room temperature, and they were visualized by
enhanced chemiluminescence (Amersham Biosciences).
The bands were acquired on the ImageQuant LAS 4000
(GE Healthcare) and quantified by ImageJ software.
Elisa assay
Osteoblast conditioned supernatants were collected and
analyzed for Sclerostin (MyBioSource, San Diego, USA)
and type 1 procollagen amino-terminal-propeptide (P1NP)
(Cusabio, Hubei Province, China) content using commer-
cially available ELISA kits according to the manufacturer’s
protocols.
Each experiment was performed in duplicate and repeated
three times. Protein secretion levels found in the supernatant
were corrected per mg of cellular protein of each dish. Total
protein concentrations were determined with the BCA
methods. Data are expressed as pg/mg protein.
Statistical analysis
Results are expressed as means± SD of at least three
independent experiments. The significance of differences
among results was evaluated using one-way ANOVA fol-
lowed by Bonferroni post-hoc test (GraphPad Prism, San
Diego, CA, USA). Data with p< 0.05 was considered
significant.
Results
Patient characteristics
Baseline characteristics of obese women enrolled in the
study were: age 53± 8.2, body weight: 101.3± 3.9 kg, BMI
37.1± 6.0 kg/m2. These sedentary obese women underwent
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specific and individualized hypocaloric diet and physical
activity protocol and significantly improved their body
composition, as shown in Table 1, with a decrease of total
body weight from 101.3± 3.9 at baseline to 91.0± 9.5* kg
after 12 months of the intervention protocol. Decrease of
body weight in obese women was due to a loss of both fat
and fat free mass (Table 1). However, when results were
carefully evaluated it was possible to note that there was a
significant decrease in the percentage of fat mass and a
significant increase of the percentage of fat free mass,
indicating a significant improvement of body composition
in term of decrease of fat tissue (Table 1). Body composi-
tion variation was achieved after 4 months and maintained
for all the intervention periods (Table 1). Due to the relative
young age of subjects, no significant alterations of inflam-
matory cytokines (i.e. interleukin-6, TNF-α, etc) were
found, thus no modulation was depicted upon physical
activity and nutritional intervention protocol (data not
shown). As expected, physical activity protocol and nutri-
tional intervention induced a time-dependent decrease of
insulin levels, without reaching statistical significance in
this population (T0: 670.23± 108.88, T4: 428.64 ± 53.87,
T6: 418.37 ± 86.04, T12: 327.47± 92.61 pg/ml). In addi-
tion, leptin levels appeared to decrease upon treatments,
without reaching significant differences (data not shown).
Wnt/β-catenin signaling in osteoblastic cells treated with
trained obese patients
Since our previous in vitro results [24] showed alteration of
β-catenin translocation induced by exposure to the sera of
obese subjects, first experiments were performed to char-
acterize intracellular signaling in osteoblasts exposed to the
sera of sedentary obese individuals at baseline and after a
physical training period. To this aim, SAOS-2 osteoblastic
cells were exposed for 48 h to sera of subjects affected by
abdominal obesity before (T0) and after 4 (T4), 6 (T6) and
12 (T12) months of hypocaloric diet and physical activity
protocol.
Exposure of osteoblasts to sera of women subjected to
physical activity, induced a time-dependent total β-catenin
increase already after 4 months of exercise and diet (T4)
compared to the cells treated with the sera of sedentary
obese individuals before the beginning of the protocol (T0)
(Fig. 1a). This positive effect progressively increased during
the physical activity-training period with a maximal effect
reached after 12 months (T12). Accordingly to the increase
Fig. 1 Analysis of total protein
content (a) and cytoplasmic and
nuclear fractions (b) of β-catenin
in SaOS-2 cells cultured in the
presence of obese women sera
before (T0) and after 4, 6, and
12 months of physical activity
protocol (T4, T6, and T12,
respectively). Total, cytoplasmic
and nuclear fractions of SAOS-2
cells were separated as described
in “Material and methods”
section. β-tubulin and histone
H3 were used as loading and
purity controls of each cellular
fraction. Results are presented as
mean± SD (n= 3) of three
separate experiments.
*** p< 0.001, ** p< 0.01 and
* p< 0.05 vs. T0-; # p< 0.05 vs.
T4- and § p< 0.05 vs. T6-
treated cells
Table 1 Body composition parameters at baseline and after 4, 6 and
12-months training period
Obese women (n= 28)
T0 T4 T6 T12
Weight (Kg) 101.3± 3.9 94.7± 3.6** 94.0± 5.5** 91.0± 9.5*
BMI (kg/m2) 38.2± 1.2 35.7± 1.1** 35.4± 1.6** 34.3± 3.0*
FFM (Kg) 56.2± 2.2 54.9± 2.2** 53.8± 3.3* 52.0± 5.7*
FFM (%) 55.5± 6.5 58.0± 5.9** 57.2± 5.6* 57.1± 5.6*
FM (%) 44.5± 1.1 42.0± 1.3** 42.8± 1.6* 40.9± 2.6**
BMI body mass index, FFM fat free mass, FM fat mass
** p ≤ 0.001 vs. T0, * p ≤ 0.05 vs. T0
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of β-catenin total protein, there was also an increase of
nuclear accumulation of this protein in cells exposed to
T12 sera (Fig. 1b). In order to investigate the sera effects on
Wnt/β-catenin pathway activity, we also evaluated protein
expression levels of TCF/LEF transcription factors and
relevant Wnt target genes including c-Myc, c-Jun Cyclin D1
and CD44.
As depicted in Fig. 2, there was a time-dependent
increase of LEF protein expression in the cells treated with
the T4, T6 and T12 women sera showing an increase in the
ratio FFM/FM as compared to cells exposed to T0 sera. A
significant increase was also been found in T6 and T12
treated cells when compared to T4-treated cells, while the
expression of TCF increased about three times with T4 sera
as compared to baseline. A return to the baseline levels was
found in T6-treated cells followed a significant increase in
T12-treated cells respect T0- and T6-treated cells (Fig. 2a).
Moreover, protein expression of Cyclin D1 increased about
two times in cells exposed to T4 maintaining high levels in
T6- and T12-treated cells. An about two-fold increase was
also found in T12 sera patients treated cells compared to
baseline levels (Fig. 2b). The expression of both c-Myc and
c-Jun, increased about two times with T4 sera compared to
T0-treated cells, without specific further stimulatory effect
at following time-points.
Interestingly, it has been recently demonstrated that
Adiponectin and its receptor AdipoR1 play crucial roles in
bone metabolism promoting osteoblastogenesis, osteoblast
differentiation both in vitro an in vivo [30–32]. Thus,
AdipoR1 was evaluated in order to further understand a
potential role of this adipokine in the results observed.
AdipoR1 protein levels increased in a time-dependent
manner with a three-fold rise in T6- and T12-treated cells
compared to baseline sera treated-cells (Fig. 3), suggesting a
potential involvement of Adiponectin/AdipoR1 pathway in
mediating improvement of osteoblast homeostasis likely by
a β-catenin signaling recovery.
Modulation in sclerostin secretion
Since preclinical studies have shown that sclerostin inhibi-
tion increases bone formation [33–35], we evaluated scler-
ostin level in cellular supernatant obtained from osteoblastic
cells treated with the sera of the obese women. A relevant
decrease of sclerostin secretion was detected in SAOS-2
osteoblastic cells treated with T4, T6, and T12 sera as
compared to T0 sera treated cells as showed in Fig. 4a.
Moreover, in the presence of T12 sera SAOS-2 cells
showed a significant increased secretion of P1NP as com-
pared to T0 sera treated cells (Fig. 4b), strongly
Fig. 2 Protein expression analysis of cofactors LEF/TCF (a) and
specific target gene of Wnt/βcatenin pathway, CD44, Cyclin D1 (b)
and c-Myc, c-Jun (c) in SAOS-2 cells treated with sera of obese
women before and after physical activity protocol. β-tubulin was used
as internal control for protein loading. Results are presented as mean±
SD (n= 3) of three separate experiments. ** p< 0.01 and *p< 0.05
vs. T0-treated cells; # p< 0.05, ## p< 0.01 vs. T4- and § p< 0.05 vs.
T6-treated cells
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demonstrating the positive effect of the change of life style
on metabolic alteration and skeletal homeostasis.
Discussion
Our results demonstrate for the first time that the sera of
obese sedentary women who improved their body compo-
sition, in terms of percentage of lean and adipose mass,
upon a physical training period and hypocaloric diet, lead
the re-establishment of osteoblast homeostasis as compared
to cells treated with sera of the same obese subjects at
baseline. In particular, sera of sedentary obese women after
physical activity protocol and hypocaloric diet, activated the
canonical Wnt/β-catenin pathway inducing an up regulation
of specific target genes with a consequent improvement
of osteoblast differentiation and activity after 4, 6, and
12 months.
Indeed, it is known that the canonical Wnt/β-catenin
pathway is essential for proliferation and survival of
osteoblasts [36]. In fact, when Wnt ligands bind to cell-
surface receptors, the intracellular protein disheveled (Dvl)
is phosphorylated activating a cascade of intracellular sig-
naling. This event induces an accumulation of β-catenin in
the cytoplasm and its translocation into the nucleus leading
to act as transcriptional coactivator factor that belong to the
TCF/LEF family linked to the modulation of target genes
expression involved in cell proliferation and differentiation
[36, 37].
Obesity and osteoporosis are two increasing health pro-
blems in many countries [1, 2]. Obese individuals are often
affected by hypertension, dyslipidaemia, diabetes mellitus
and cardiovascular diseases [1, 2]; on the opposite, osteo-
porosis is a bone metabolic disease characterized by skeletal
fragility, inducing an increased risk of developing sponta-
neous and traumatic fractures [6–8]. Both osteoporosis and
obesity have been defined social diseases due to their high
impact on mortality and morbidity, but also for the altera-
tions in the quality of life of patients affected by these two
diseases [7]. Body fat and lean mass are linked to bone
mineral density, with obesity apparently exerting protection
against bone loss after menopause [6–8]. The pathophy-
siological relevance of adipose tissue for skeletal integrity
probably resides in the role of several adipokines in bone
remodeling regulating both formation and resorption. For
instance, serum Adiponectin level is reduced in obese
subjects and increased after weight loss [38, 39] and Adi-
ponectin /AdipoR1 pathway has received great attention
due to its key role in influencing bone metabolism. Indeed,
it stimulates osteoblasts proliferation and differentiation and
increases bone formation [30–32], highlighting its impor-
tant role as contributor to the fat-bone relationship. In fact,
Lin et al. [32] indicated that AdipoR1 increases bone for-
mation in mice and regulates osteoblasts differentiation
through GSK-3β and β-catenin signaling. Indeed, our
in vitro results indicate a recovery of β-catenin signaling,
suggesting that the improved cell homeostasis observed in
osteoblasts treated with the sera of trained obese women
could be due to a restored activity of this transduction
pathway. Moreover, the increased AdipoR1 levels further
suggest a potential involvement of Adiponectin/AdipoR1
Fig. 3 Protein expression analysis of Adiponectin receptor 1 (Adi-
poR1) in SAOS-2 cells cultured in the presence of obese women sera
before (T0) and after 4, 6, and 12 months of physical activity protocol
(T4, T6, and T12, respectively). β-tubulin was used as internal control
for protein loading. Results are presented as mean ± SD (n= 3) of
three separate experiments. * p< 0.05 vs. T0-treated cells
Fig. 4 Effect of obese women
sera before and after diet and
physical training protocol on
secretion of Sclerostin (a) and
P1NP (b) release in culture
medium of SAOS-2 cells.
Results are normalized to
protein content and represent
mean± SD of six different
wells. * p< 0.05 vs. T0-;
## p< 0.01 vs. T4- and §§§ p<
0.001 vs. T6-treated cells
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pathway in mediating β-catenin signaling recovery and
improved osteoblast homeostasis.
Certainly, the cross-talk between fat and the skeleton
constitutes a homeostatic feedback system in which adipo-
kines and molecules secreted by osteoblasts represent the
link of an active bone–adipose axis [21–24]. However, the
mechanism(s) by which all these events occur have not been
fully characterized yet. In particular, even though several
data indicate that overweight women are protected from
osteoporosis [8, 9], an increasing number of evidence [13]
seems to show conflicting results regarding this issue,
suggesting instead that obesity might actually interfere with
bone health. Our previous results have shown that obese
patients might indeed have disruption of skeletal metabo-
lism, often showing an alteration of bone density or bone
quality [22, 40]. Moreover, recent published data obtained
in healthy premenopausal women, showed that higher
abdominal adipose mass was associated with poorer bone
quality, as supported by lower trabecular bone volume
fraction, fewer and thinner trabeculae, lower trabecular
stiffness, and higher cortical porosity [40]. In addition, the
study also depicted lower trabecular bone volume fraction
and decreased bone formation in vivo [40]. Indeed, our
previous in vitro results supported the role of an altered
bone formation in the skeletal alterations described in obese
subjects [24], further emphasizing that the mechanisms
underlying the observed alterations are likely due to a
damaged pattern of osteoblastic differentiation by an
alteration of Wnt/β-catenin pathway [25].
Our previous data demonstrated that Wnt/β-catenin
pathway is one of the molecular intracellular pathway
involved in the gene expression modulation disrupted in the
osteoblasts exposed to sera of obese sedentary women [25].
Indeed, we demonstrated that GSK3β, a key modulator of β-
catenin activity, was repressed by phosphorylation at ser-9.
Consequently β-catenin was slightly detectable in the
cytoplasm, responsive genes were down-modulated and
osteoblast differentiation and activity disrupted in the cells
[25]. The results presented in this manuscript show that an
improvement of body composition, likely leading to an
improvement of circulating factors among which probably
Adiponectin play an important role ameliorating osteoblasts
differentiation and activity in vitro.
In regards of the Wnt/β-catenin molecular pathway, an
interesting result is linked to the evaluation and character-
ization of LEF1 modulation. LEF1 contains two promoters
that drive expression of a full-length protein (LEF1) and a
N-terminally truncated isoform (LEF1-ΔN) [41–43]. Inter-
estingly, while the sera of sedentary obese women blunted
expression of LEF1-ΔN [25], sera of the same patients,
undergoing physical activity training induced a significant
increase of LEF/TCF transcription factors. Moreover, spe-
cific target genes of Wnt/βcatenin pathway, CD44, Cyclin
D1 significantly increased, further indicating that modula-
tion of this intracellular signaling in obese subjects might
play a pivotal role in the modulation of osteoblastic cells
differentiation.
Indeed, physical activity seems to play an important role
in maintaining skeletal health homeostasis by stimulating
bone formation, through a mechanical action on osteoblasts
and osteocytes [44, 45]. In addition, some recent studies
seem to support a role of physical activity in the modulation
of sera soluble factors, which might act on skeletal cells
improving bone homeostasis [46]. Indeed the results of our
study further support a role for physical activity in acti-
vating bone formation pattern by a modulation of intracel-
lular pathways not only by a direct mechanic loading, but
also by the ability of improving body composition and
serum factors milieu. More interestingly, our patients were
highly compliant to the physical exercise training since
intervention protocol was individually planned and pre-
scribed upon evaluation of basal physical capacity [28].
This positive effect of physical activity on body composi-
tion and, also, on osteoblastic cells homeostasis in vitro
might further highlight the cellular and molecular mechan-
isms which positively regulate bone homeostasis as also
described by others [47], further encouraging physicians
and care givers to convince sedentary obese individuals to
exercise even at low level of intensity.
We understand that a potential limitation of our study is
linked to the fact that we have used a clonal osteoblastic cell
line in vitro model system to characterize the molecular/
cellular events. However, it is well known that molecular or
cellular mechanism(s) described in cellular model system
are usually confirmed in primary cell lines, which we will
evaluate as well.
Moreover, although it is indisputable the importance to
accompany the analysis of proteins expression with those of
mRNA level, the amount of sera, available for this study,
was not enough to perform both analysis. However, despite
this limitation, our previous published study [25] showed a
tight correspondence of protein and mRNA levels in SAOS-
2 cells exposed to the sera of both obese patients and normal
weight subjects.
In conclusion, we have described for the first time that the
sera of obese sedentary women who improved their body
composition, in terms of percent of lean and adipose mass,
upon a physical training protocol, induce a significant
improvement in osteoblast homeostasis as compared to cells
treated with sera of the same obese subjects at baseline. Fur-
ther studies are needed to fully characterize all events involved
in the improvement of cells activity in vitro and in vivo.
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